Although IL-33 is a potent inducer of ILC2-mediated type 2 inflammation, it also has a protective role in various diseases, such as myocardial infarction, stroke, and atherosclerosis.40–42 Thus, it is possible that an anti-IL-33 antibody may have unfavorable adverse effects for these diseases. Here, IL33 is linked to myocardial infarction.